Heron Therapeutics, Inc. (HRTX)
NCM – Real vaqt narxi. Valyuta: USD
0.43
+0.02 (4.88%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.44
+0.01 (1.74%)
Bozordan keyin: Jun 26, 2026, 7:47 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
0.43
+0.02 (4.88%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.44
+0.01 (1.74%)
Bozordan keyin: Jun 26, 2026, 7:47 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 2.53 | 6.05 | 10 | |
| Tezkor likvidlik nisbati | 1.51 | 5.63 | 8.0 | |
| Qarz/Kapital nisbati | 15.50 | 0.30 | 2.0 | |
| Qarz/Aktivlar nisbati | 0.58 | 1.04 | 4.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 5.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 108M | 127M | 144M | 155M | 151M |
| Yalpi foyda | 53M | 62M | 106M | 114M | 107M |
| Operatsion daromad | -169M | -111M | -12M | -3M | -10M |
| Sof foyda | -182M | -111M | -14M | -20M | -31M |
| EBITDA | -166M | -108M | -9M | -224K | -8M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 13.24 | 66.67 | 9.0 |
| Keyingi chorak | 12.88 | 93.33 | 9.0 |
| Joriy yil | 8.52 | 55.56 | 8.0 |
| Keyingi yil | 4.63 | 81.25 | 7.0 |
| O‘rtacha ball | 8.3 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | -14.47 | -174.57 | -99.99 | 78.97 | 3.3 |
| Yil/Yil | -10.77 | -407.81 | -499.99 | 78.49 | 3.3 |
| 3 yil o‘rtacha | 12.97 | 26.09 | 35.84 | 34.71 | 9.5 |
| 5 yil o‘rtacha | 12.21 | 19.74 | 28.68 | 24.87 | 9.0 |
| O‘rtacha ball | 6.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | Yo'q | 1.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 1.0 | |
Umumiy qarz $141.6M naqd pul zahiralaridan ($26.1M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $229.0M jami joriy majburiyatlardan $90.5M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (15.5) tarmoq o'rtachasidan ancha yuqori bo'lib, haddan tashqari leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
Salbiy erkin pul oqimi -$1.9M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi